ChengDa Pharmaceuticals Co Ltd Sustainability Reports
The company operates as a contract development and manufacturing organization (CDMO) providing key pharmaceutical intermediates and active pharmaceutical ingredients (APIs). It also engages in the research, production, and sales of L-carnitine products.
Sector: Manufacturing
Country: China
Exchange: Shenzhen Stock Exchange
FIGI: BBG001V0XQY1
1 reports from 2023 to 2023
